We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDci Advisors Regulatory News (DCI)

Share Price Information for Dci Advisors (DCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.75
Bid: 4.50
Ask: 5.00
Change: -0.09 (-1.86%)
Spread: 0.50 (11.111%)
Open: 4.75
High: 4.75
Low: 4.75
Prev. Close: 4.84
DCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on legal actions

2 Apr 2024 15:33

RNS Number : 0228J
DCI Advisors Limited
02 April 2024
 

DCI Advisors Limited

(the "Company" or "DCI")

Update on legal actions with Dolphin Capital Partners Limited

 

2 April 2024

 

Following the Company's litigation update published on 28 March 2024, the Board of DCI has been made aware that its former manager, Dolphin Capital Partners Limited ("DCP"), has contacted a number of DCI's shareholders with claims that the litigation being pursued by DCI against DCP could prove unaffordable for DCI. Following receipt of such communication from DCP, one shareholder has even suggested that DCI obtains third party funding for its litigation against DCP.

 

The DCI board therefore wishes to advise shareholders that it started exploring litigation funding for most of its litigation against DCP from a third party in 2023, with a funding agreement signed earlier this year.

 

Further, concerning DCI's litigation against DCP and individuals associated with DCP in Greece, DCI has the funding in place to carry the litigation to its conclusion, with a maximum cost to DCI estimated at approximately €100,000. DCI's directors believe that for such a modest cost it is overwhelmingly in the best interest of shareholders as a whole that this litigation is pursued, as the advice provided to the Company is that the financial upside the Company could expect from success is currently c.€57.0 million, with the potential for this amount to increase. The litigation funding that DCI has secured will mitigate DCI's legal costs in pursuing this claim and means that DCI is well positioned to continue to their conclusion all its legal cases and claims against DCP.

 

The Board of DCI would also like to use this opportunity to respond to DCP's misleading statement that this €57.0 million claim only relates to the Amanzoe option. This is incorrect. Many different claims have been made and these are unrelated to the Amanzoe option.

 

The Directors anticipate that they will release a general update on DCI and its portfolio next week.

 

Enquiries

DCI Advisors Ltd

Nicolai Huls / Nick Paris, Managing Directors

 

nickparis@btinternet.com

+44 (0) 7738 470550

Cavendish Capital Markets (Nominated Adviser & Broker)

James King / Jonny Franklin‐Adams / Edward Whiley / Oscar Valeur‐Adu (Corporate Finance)

Pauline Tribe (Sales)

 

 

+44 (0) 20 7220 0500

FIM Capital Limited (Administrator)

Lesley Lennon / Grainne Devlin (Corporate Governance)

llennon@fim.co.im / gdevlin@fim.co.im

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDITMITMTJMBTI
Date   Source Headline
29th Apr 202411:32 amRNSHolding(s) in Company
16th Apr 202412:38 pmRNSShareholder Loan & Related Party Transaction
15th Apr 20242:26 pmRNSShareholder Update
2nd Apr 20243:33 pmRNSUpdate on legal actions
28th Mar 20249:43 amRNSLegal Update
14th Mar 20242:57 pmRNSFurther Shareholder Loan and RPT
27th Feb 20242:17 pmRNSHolding(s) in Company
23rd Feb 20245:00 pmRNSHolding(s) in Company
9th Feb 20245:07 pmRNSFurther Shareholder Loan
9th Feb 20243:39 pmRNSHolding(s) in Company
27th Dec 20232:23 pmRNSGovernment Grant to the Kilada Project
15th Dec 20239:36 amRNSResult of AGM
13th Dec 20238:53 amRNSShareholder Loan
13th Dec 20238:46 amRNSUpdate on legal actions
1st Dec 20233:44 pmRNSHolding(s) in Company
22nd Nov 202312:32 pmRNSAGM Timing
21st Nov 202311:30 amRNSNotice of AGM
16th Nov 20233:31 pmRNSShareholder Loan
6th Oct 20232:17 pmRNSShareholder Loan
29th Sep 20237:00 amRNSHalf-year Report
14th Sep 202312:32 pmRNSShareholder Loans and a Related Party Transaction
7th Sep 20234:17 pmRNSHolding(s) in Company
30th Aug 202310:22 amRNSDirector/PDMR Shareholding
29th Aug 202310:07 amRNSDirector/PDMR Shareholding
21st Aug 202311:46 amRNSHolding(s) in Company
8th Aug 20239:23 amRNSDirector/PDMR Shareholding
3rd Aug 20234:35 pmRNSDirector/PDMR Shareholding
1st Aug 20234:33 pmRNSNotification of Transaction of a PCA
27th Jul 20233:14 pmRNSDirector/PDMR Shareholding
30th Jun 20231:25 pmRNSAnnual Financial Report
29th Jun 20234:50 pmRNSShareholder Loans
7th Jun 20237:00 amRNSChange of Name
26th May 20232:19 pmRNSShareholder Loans
26th May 20239:41 amRNSKilada Funding
3rd May 20234:24 pmRNSHolding(s) in Company
28th Apr 20239:41 amRNSShareholder Loans
27th Apr 20232:45 pmRNSHolding(s) in Company
19th Apr 20237:00 amRNSShareholder Loans and Related Party Transaction
18th Apr 202310:30 amRNSShareholder Update
13th Apr 20234:21 pmRNSHolding(s) in Company
13th Apr 20233:58 pmRNSHolding(s) in Company
11th Apr 20234:36 pmRNSHolding(s) in Company
11th Apr 20233:12 pmRNSFiling of Claim Form
6th Apr 20234:50 pmRNSHolding(s) in Company
5th Apr 20234:39 pmRNSNew website now live
31st Mar 20236:13 pmRNSCompany Website
20th Mar 20237:00 amRNSTermination of Inv. Manager & Removal of Director
17th Feb 20233:48 pmRNSHolding(s) in Company
13th Feb 20237:00 amRNSDirectorate Change
23rd Dec 20229:07 amRNSCompletion of disposal of interest in OOKI

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.